Axon is evolving from a hardware-centric TASER/body-camera vendor into the operating system for public safety — a vertically integrated platform spanning the entire 'call-to-closure' workflow from 911 intake (Carbyne) through dispatch, field response (TASER + body cameras + drones), evidence management (Evidence.com), AI-assisted report writing (Draft One), records management (Axon Records), and real-time operations (Fusus). With $14.4B in contracted backlog, $1.3B ARR growing 35% YoY, 125% NRR, and a $160B+ TAM of which it has penetrated less than 2%, Axon is a rare compounder with durable switching costs, mission-critical positioning, and a long runway for both organic and inorganic growth.
| Scenario | Prob. | Target | Driver |
|---|---|---|---|
| Bull | 25% | $643.00 | FY2026 revenue growth exceeds 30% guidance high-end — AI products (Draft One, Axon Assistant) drive outsized adoption |
| Base | 50% | $482.00 | FY2026 revenue growth meets 27-30% guidance — in-line execution on existing product portfolio |
| Bear | 25% | $285.00 | Federal budget cuts materially reduce DOJ grantmaking — new contract signings slow 20%+ in FY2026 |
Counter-drone contract momentum ahead of 2026 FIFA World Cup
Q1 2026 earnings beat + FY2026 guidance raise
Phase A deep research — initial thesis creation
None mapped.
Positioning skews toward near-term upside